Helen Rees

Last updated

Professor Helen Rees OBE GCOB [1] D.Sc. Medicine (honoris causa) LLD (honoris causa) [2] is a medical doctor, and the founder and executive director of Wits RHI, the largest research Institute at the University of the Witwatersrand in Johannesburg, South Africa. She is a Personal Professor in the University of Witwatersrand's Department of Obstetrics and Gynaecology, co-director and co-founder of the Wits African Leadership in Vaccinology Expertise (ALIVE [3] ), Honorary Professor in the Department of Clinical Research at the London School of Hygiene and Tropical Medicine and an Honorary Fellow at Cambridge University's Murray Edwards College, UK.

Contents

Early life and education

Rees obtained her Medical Degree and Masters in Social and Political Sciences from New Hall College (now Murray Edwards College) at Cambridge University, and is now a Fellow of the college. [4] For her master's degree, Rees combined social science with medical science by describing the adverse impact that the poorly managed elective induction of labour was having on both obstetric outcomes and on the experiences of women in labour.  

Rees is an alumnus of Harvard Business School having completed the HBS Senior Executive Programme for Southern Africa.

Career

Rees is internationally recognised as an award-winning global health practitioner who has dedicated her professional career to improving public health in Africa, with a focus on HIV, vaccine preventable diseases, women's health and medicines regulation. [5] In 2018, she served as the chief investigator of FACTS 001, an African follow-up study to the smaller trial from 2010, which showed that South African women who used a vaginal gel containing tenofovir before and after sex were better protected from HIV than women who did not. [6]

Rees has also chaired over 100 national and international scientific and policy committees, has over 250 [7] scientific academic publications, [8] has delivered over 400 invited plenary and keynote addresses, and contributed to the organisation of more than 100 conferences.

Committees and advisory work

Rees has served on and chaired many national and global scientific committees and boards and is widely respected for her ability to synthesize recommendations from multifaceted inputs and to link research to policy and has successfully chaired many national, regional and global committees in deliberations that have changed key strategies and policies in the African region. Rees has led national consultations at the invitation of the Ministries of Health in South Sudan, Ethiopia, Nigeria and the Democratic Republic of Congo. She is a keen advocate for increasing research capacity in LMICs.

Rees has served on expert structures and committees for WHO, UNAIDS, UNICEF, the Global Alliance for Vaccines and Immunisation and the Bill & Melinda Gates Foundation. She was the Chair of the WHO's Strategic Advisory Group of Experts on Immunization [9] and she now chairs the WHO's African Regional Technical Advisory Group on Immunization. 

Rees is recognised as a leader in global health policy and security. She has served on and chaired a number of WHO International Health Regulation (IHR) Emergency Committees. She is the Chair of WHO's IHR Emergency Committee on Polio. She co-Chairs the SAGE working group on Ebola Vaccines [10] and is a member of WHO's Scientific and Technical Advisory Group on Infectious Hazards. She is a steering committee member of the Coalition for Clinical Research for Pandemics that focuses on research priorities in low- and middle-income countries. From 2015 to 2016, she was a member of the Review Committee on the Role of the International Health Regulations (2005) in the Ebola Outbreak and Response tasked with making recommendations to WHO about steps required to improve the global response to public health emergencies. She was the Chair of the WHO SAGE Committee on the Use of Vaccines in Humanitarian Emergencies.

In the field of vaccines and epidemics Rees chairs the Gavi Vaccine Investment Strategy that is developing a priority list for procurement of vaccines between 2025 and 2030 for the world's poorest 71 countries.

Other activities

Government organizations

Non-profit organizations

Recognition

Honours

Rees has won many international and national awards for her contribution to global health and to science, specifically in 2001 receiving the Order of the British Empire [16] by Queen Elizabeth II. In 2016 she was awarded the South African National Order of the Baobab by the President of South Africa for exceptional and distinguished contributions in medicine. [17] In 2022, Rees received the platinum South African National Batho Pele Award for excellence in contribution to the South African COVID-19 response [18] and was made an Officer of the French National Order of Merit in the same year by President Emmanuel Macron for her contribution to global health and to the COVID-19 response. In 2022 the Harvard Public Health named Rees a ‘standout voice’ in African public health. [19]

Awards

In 2015, Rees was awarded the National Science and Technology Foundations’ Lifetime Achievement Award as well as the Harry Oppenheimer Fellowship [20] given to a leading scholar who has a sustained a record of outstanding research and intellectual achievement at the highest level. In 2006 she was elected as a member of the Academy of Science of South Africa (ASSAf) member, and in 2010 was awarded the SA Academy of Science's Gold Award for outstanding achievement in scientific thinking to the benefit of society. She was awarded Wits University's Vice-Chancellor's Research Award (2012), Wits’ highest research recognition, and Wits Faculty of Health Sciences recognition for dedication and achievement in research (2013). She was the London School of Hygiene and Tropical Medicine's 2011 International Heath Clark lecturer awarded to an outstanding global health practitioner. The South African National Research Forum rates her as an outstanding international scientist. She was the first person to receive the SA Department of Science and Technology's award for the ‘Distinguished Scientist recognised for outstanding contribution to improving the quality of life of women’ (2006).

Honorary degrees

Rees holds a Doctor of Science (Medicine) honoris causa from the University of London and a Doctor of Laws honoris causa from Rhodes University, South Africa.

Related Research Articles

<span class="mw-page-title-main">Peter Piot</span> B lgian microbiologist (born 1949)

Sir Peter Karel, Baron Piot, is a Belgian-British microbiologist known for his research into Ebola and AIDS.

David L. Heymann is an American infectious disease epidemiologist and public health expert, based in London.

<span class="mw-page-title-main">Awa Marie Coll-Seck</span> Senegalese infectious diseases specialist and politician

Awa Marie Coll-Seck is as Senegalese infectious diseases specialist and politician who served as Minister of Health of Senegal from 2001 to 2003 and again from 2012 to 2017. She also served as former Executive Director of the Roll Back Malaria Partnership and is on the board of directors of several notable global health organizations. She is an agenda contributor of the World Economic Forum.

Frederick A. Murphy is a retired American virologist. He was a member of the team of scientists that discovered the Ebola virus at the Centers for Disease Control and Prevention (CDC), where he served as Chief of Viropathology, near Emory University in Atlanta, Georgia, in 1976, and is internationally known for his work on rabies, encephalitis and hemorrhagic fevers, with over 250 peer-reviewed journal articles. Murphy was as an electron microscopy pioneer in the field of virology, best recognized for obtaining the first electron micrograph of an Ebola viral particle at the CDC in 1976.

<span class="mw-page-title-main">K. Srinath Reddy</span>

K. Srinath Reddy is an Indian physician and the Former President of the Public Health Foundation of India and formerly headed the Department of Cardiology at All India Institute of Medical Sciences (AIIMS).

<span class="mw-page-title-main">Agnes Binagwaho</span> Rwandan pediatrician

Agnes Binagwaho is a Rwandan Politian, pediatrician and co-founder and the former vice chancellor of the University of Global Health Equity (2017-2022). In 1996, she returned to Rwanda where she provided clinical care in the public sector as well as held many positions including the position of Permanent Secretary for the Ministry of Health of Rwanda from October 2008 until May 2011 and Minister of Health from May 2011 until July 2016. She has been a professor of global health delivery practice since 2016 and a professor of pediatrics since 2017 at the University of Global Health Equity. She resides in Kigali.

<span class="mw-page-title-main">Jeremy Farrar</span> British medical researcher

Sir Jeremy James Farrar is a British medical researcher who serves as Chief Scientist at the World Health Organization since 2023. He was previously the director of The Wellcome Trust from 2013 to 2023 and a professor of tropical medicine at the University of Oxford.

Jon Andrus, an American physician, epidemiologist and immunization specialist, is the former deputy director of the Pan American Health Organization (PAHO).

<span class="mw-page-title-main">Glenda Gray</span> South African researcher

Glenda Elisabeth GrayMB BCh, FC Paeds, DSc (hc), is a South African physician, scientist and activist specializing in the care of children and in HIV medicine. In 2012, she was awarded South Africa's highest honour, the Order of Mapungubwe (Silver). She became the first female president of the South African Medical Research Council in 2014, was recognized as one of the "100 Most Influential People" by Time in 2017 and was listed amongst "Africa's 50 Most Powerful Women" by Forbes Africa in 2020. Her research expertise involves developing microbicides for sexually transmitted diseases and HIV vaccines.

<span class="mw-page-title-main">Quarraisha Abdool Karim</span>

Quarraisha Abdool Karim is an infectious diseases epidemiologist and co-founder and Associate Scientific Director of CAPRISA. She is a Professor in Clinical Epidemiology, Columbia University, New York and Pro-Vice Chancellor for African Health, University of KwaZulu-Natal, South Africa.

<span class="mw-page-title-main">Salim Abdool Karim</span> South African medical researcher

Salim S. Abdool Karim, MBChB, MMed, MS(Epi), FFPHM, FFPath (Virol), DipData, PhD, DSc(hc), FRS is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives.

<span class="mw-page-title-main">Matshidiso Moeti</span>

Matshidiso Rebecca Natalie Moeti is a physician, public health specialist and medical administrator from Botswana who has been serving as Regional Director of the World Health Organization Regional Office for Africa (AFRO), headquartered in Brazzaville, the Republic of the Congo, since 2015.

<span class="mw-page-title-main">Soumya Swaminathan</span> Indian and WHO Deputy Director general

Soumya Swaminathan is an Indian paediatrician and clinical scientist known for her research on tuberculosis and HIV. From 2019 to 2022, she served as the chief scientist at the World Health Organization under the leadership of Director General Tedros Adhanom Ghebreyesus. Previously, from October 2017 to March 2019, she was the Deputy Director General of Programmes (DDP) at the World Health Organization.

Gary J. Nabel is an American virologist and immunologist who is President and chief executive officer of ModeX Therapeutics in Natick, Massachusetts. He was the founding director of Vaccine Research Center at the National Institute of Allergy and Infectious Diseases.

<span class="mw-page-title-main">Marie-Paule Kieny</span> French virologist and science writer

Marie-Paule Kieny is a French virologist, vaccinologist, public health expert and science writer. She is currently director of research at INSERM and chief of the board at DNDi.

<span class="mw-page-title-main">Helen McShane</span> British virologist

Helen Irene McShane is a British infectious disease physician and a professor of vaccinology, in the Jenner Institute at the University of Oxford, where she has led the tuberculosis vaccine research group since 2001. She is senior research fellow at Harris Manchester College, Oxford.

The Strategic Advisory Group of Experts (SAGE) is the principal advisory group to World Health Organization (WHO) for vaccines and immunization. Established in 1999 through the merging of two previous committees, notably the Scientific Advisory Group of Experts and the Global Advisory Group by Director-General of the WHO Gro Harlem Brundtland. It is charged with advising WHO on overall global policies and strategies, ranging from vaccines and biotechnology, research and development, to delivery of immunization and its linkages with other health interventions. SAGE is concerned not just with childhood vaccines and immunization, but all vaccine-preventable diseases. SAGE provide global recommendations on immunization policy and such recommendations will be further translated by advisory committee at the country level.

<span class="mw-page-title-main">Shabir Madhi</span> South African physician and professor

Shabir Ahmed Madhi, is a South African physician who is professor of vaccinology and director of the South African Medical Research Council Respiratory and Meningeal Pathogens Research Unit at the University of the Witwatersrand, and National Research Foundation/Department of Science and Technology Research Chair in Vaccine Preventable Diseases. In January 2021, he was appointed Dean of the Faculty of Health Sciences at the University of the Witwateratand.

Misaki Wayengera is a Ugandan physician, academician, and a medical researcher. He serves as a lecturer for Pathology, Immunology and Molecular Biology at Makerere University College of Health Sciences. He is the chairperson of Uganda's Scientific Advisory Committee on COVID-19 for the Ministry of Health and the National Task Force.

Gary P. Kobinger is a Canadian immunologist and virologist who is currently the director at the Galveston National Laboratory at the University of Texas. He has held previous professorships at Université Laval, the University of Manitoba, and the University of Pennsylvania. Additionally, he was the chief of the Special Pathogens Unit at the National Microbiology Laboratory (NML) of the Public Health Agency of Canada (PHAC) in Winnipeg, Manitoba, for eight years. Kobinger is known for his critical role in the development of both an effective Ebola vaccine and treatment. His work focuses on the development and evaluation of new vaccine platforms and immunological treatments against emerging and re-emerging viruses that are dangerous to human health.

References

  1. ↑ "Prof Helen Rees: The Order of the Baobab in Silver". www.thepresidency.gov.za. 13 September 2023.
  2. ↑ "Rhodes University honours global health researcher Professor Helen Rees". www.ru.ac.za. 13 September 2023. Retrieved 13 September 2023.
  3. ↑ "Wits ALIVE Consortium Members". www.witsalive.co.za. 13 September 2023.
  4. ↑ "Professor Helen Rees, Honorary Fellow, Murray Edwards College, Cambridge University, UK". www.murrayedwards.cam.ac.uk. 13 September 2023. Retrieved 13 September 2023.
  5. ↑ Huisman, Bienne (21 November 2022). "Face to Face: Prof Helen Rees on SAHPRA, women's rights, and her appetite for justice". Spotlight. Retrieved 13 September 2023.
  6. ↑ Donald G. McNeil Jr. (24 February 2015), Study That Paid Patients to Take H.I.V. Drugs Fails New York Times .
  7. ↑ "Research Gate: Helen Rees". ResearchGate. 13 September 2023. Retrieved 13 September 2023.
  8. ↑ "Google Scholar Helen Rees Citations". Google Scholar Helen Rees. 13 September 2023. Retrieved 13 September 2023.
  9. ↑ "Strategic Advisory Group of Experts on Immunization (SAGE)". World Health Organisation Strategic Advisory Group of Experts on Immunization (SAGE). 13 September 2023. Retrieved 13 September 2023.
  10. ↑ Andrew Ward (9 January 2015), Two Ebola vaccines given go-ahead for trials in west Africa Financial Times .
  11. ↑ "SAHPRA Board". South African Health Products Regulatory Authority. 13 September 2023. Retrieved 13 September 2023.
  12. ↑ Board South African Health Products Regulatory Authority (SAHPRA).
  13. ↑ David Pilling and Joseph Cotterill (9 February 2021), South Africa forced to overhaul vaccine plan over variant fears Financial Times .
  14. ↑ "MedAccess Board". MedAccess. 13 September 2023. Retrieved 13 September 2023.
  15. ↑ Steering Committee Coalition for Equitable ResearCh in Low-resource sEttings (CERCLE).
  16. ↑ "Professor Helen Rees challenges the HIV field". London School of Hygiene & Tropical Medicine. 3 June 2014. Retrieved 19 February 2017.
  17. ↑ "Prof Helen Rees". The Presidency, Republic of South Africa. Retrieved 18 April 2020.
  18. ↑ Child, Katherine (9 April 2020). "Helen Rees: The prof leading SA's Covid-19 drug trial". Financial Mail. Retrieved 13 September 2023.
  19. ↑ "Standout voices in African public health". harvardpublichealth.org. 13 September 2023. Retrieved 13 September 2023.
  20. ↑ Blaine, Sue (13 September 2023). "Helen Rees awarded R1.5m Oppenheimer fellowship". Business Live. Retrieved 13 September 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.